{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:27:19Z","timestamp":1787113639897,"version":"build-2736575974"},"reference-count":183,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401142"],"award-info":[{"award-number":["82401142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405493"],"award-info":[{"award-number":["82405493"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82501100"],"award-info":[{"award-number":["82501100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82401142"],"award-info":[{"award-number":["82401142"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["82405493"],"award-info":[{"award-number":["82405493"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["82501100"],"award-info":[{"award-number":["82501100"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Foundation","award":["L2510105"],"award-info":[{"award-number":["L2510105"]}]},{"name":"Beijing High-Level Innovation and Entrepreneurship Talent Support Program Young Backbone Talent Projects","award":["G202532301"],"award-info":[{"award-number":["G202532301"]}]},{"name":"Young Scientist Program","award":["YSP202311"],"award-info":[{"award-number":["YSP202311"]}]},{"name":"Beijing Stomatological Hospital, Capital Medical University","award":["CXJJ25109"],"award-info":[{"award-number":["CXJJ25109"]}]},{"name":"Beijing Municipal Administration of Hospitals Incubating Program","award":["PX2024055"],"award-info":[{"award-number":["PX2024055"]}]},{"award":["PX2024055"],"award-info":[{"award-number":["PX2024055"]}],"id":[{"id":"https:\/\/ror.org\/04baakq55","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Issues Mol. Biol.","CIMB"],"abstract":"<jats:p>Bisphosphonates (BPs) are cornerstone therapeutic agents for the management of metabolic bone disorders and skeletal complications associated with malignant tumors. However, their long-term administration is accompanied by the risk of developing bisphosphonate-related osteonecrosis of the jaw (BRONJ). In recent years, the pathogenesis of BRONJ has remained a major focus at the intersection of osteoimmunology and oral medicine. This review systematically summarizes the latest advances in the understanding of BRONJ pathogenesis, including the direct disruption of osteoclast differentiation and bone remodeling coupling by bisphosphonates, the systemic reprogramming of immune cell subsets and inflammatory signaling pathways, the multifaceted suppression of angiogenesis and the endothelial\u2013stromal\u2013immune axis, and the toxic impairment of oral soft tissue repair capacity. Building upon these mechanistic insights, we further discuss the modifying and synergistic effects of local oral risk factors, microbial dysbiosis, systemic comorbidities, and genetic susceptibility on the initiation and progression of BRONJ. Furthermore, emerging therapeutic strategies targeting these pathogenic mechanisms are highlighted, including restoration of small GTPase prenylation through modulation of metabolic pathways, reconstruction of T-cell subset homeostasis via immunomodulatory approaches, enhancement of local vascularization through pro-angiogenic interventions, and preservation of soft tissue barrier integrity. Collectively, this review provides a comprehensive and multidimensional overview of the pathological landscape of BRONJ and offers a theoretical framework for clinical risk stratification and the development of personalized prevention and treatment strategies.<\/jats:p>","DOI":"10.3390\/cimb48080835","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:42:17Z","timestamp":1786974137000},"page":"835","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New Immunological Insights into Bisphosphonate-Related Osteonecrosis of the Jaw: A Multidimensional Reappraisal from Molecular Switches to Clinical Phenotypes"],"prefix":"10.3390","volume":"48","author":[{"given":"Yao","family":"Li","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, School of Stomatology, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengao","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, School of Stomatology, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine, School of Stomatology, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaochen","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, School of Stomatology, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, School of Stomatology, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, School of Stomatology, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0672-0565","authenticated-orcid":false,"given":"Wen","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, School of Stomatology, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, School of Stomatology, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e179942","DOI":"10.1172\/JCI179942","article-title":"Bisphosphonates for osteoporosis: From bench to clinic","volume":"134","author":"Bellido","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/187152012799014959","article-title":"The chemistry of bisphosphonates: From antiscaling agents to clinical therapeutics","volume":"12","author":"Widler","year":"2012","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jama.2025.6003","article-title":"Osteoporosis: A Review","volume":"334","author":"Morin","year":"2025","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.annonc.2025.07.005","article-title":"STAMPEDE Trial Investigators. Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: Secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data","volume":"36","author":"Jones","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.21.02647","article-title":"Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update","volume":"40","author":"Eisen","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/ANNALS-25-03693","article-title":"Efficacy and Safety of Bisphosphonates for Complex Regional Pain Syndrome: A Systematic Review and Meta-analysis","volume":"179","author":"Ferraro","year":"2026","journal-title":"Ann. Intern Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"104502","DOI":"10.1016\/j.breast.2025.104502","article-title":"Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4\/6 inhibitors","volume":"82","author":"Scafetta","year":"2025","journal-title":"Breast"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1111\/odi.15373","article-title":"Effects of Bisphosphonates and Denosumab on Dental Implants: A Systematic Review With Meta-Analysis","volume":"31","author":"Lin","year":"2025","journal-title":"Oral Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1038\/sj.bdj.2013.327","article-title":"A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King\u2019s College Hospital","volume":"214","author":"Taylor","year":"2013","journal-title":"Br. Dent. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"115493","DOI":"10.1016\/j.bone.2020.115493","article-title":"Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton","volume":"139","author":"Rogers","year":"2020","journal-title":"Bone"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","article-title":"Biochemical and molecular mechanisms of action of bisphosphonates","volume":"49","author":"Rogers","year":"2011","journal-title":"Bone"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1359\/jbmr.1997.12.9.1358","article-title":"Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5\u2032-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro","volume":"12","author":"Frith","year":"1997","journal-title":"J. Bone Min. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0026-895X(24)12222-5","article-title":"Further insight into mechanism of action of clodronate: Inhibition of mitochondrial ADP\/ATP translocase by a nonhydrolyzable, adenine-containing metabolite","volume":"61","author":"Lehenkari","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"102534","DOI":"10.1016\/j.jormas.2025.102534","article-title":"Dual effects of bisphosphonates on bone metabolism and implant osseointegration: Mechanisms, risks and clinical strategies","volume":"126","author":"Liu","year":"2025","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cpt.2025.06.004","article-title":"Mevalonate pathway in pancreatic ductal adenocarcinoma: Mechanisms driving metabolic and cellular plasticity","volume":"4","author":"Duttenhefner","year":"2025","journal-title":"Cancer Pathog. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.biotechadv.2016.03.005","article-title":"The potential of the mevalonate pathway for enhanced isoprenoid production","volume":"34","author":"Liao","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ricco, N., and Kron, S.J. (2023). Statins in Cancer Prevention and Therapy. Cancers, 15.","DOI":"10.3390\/cancers15153948"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abbi.1999.1502","article-title":"Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase","volume":"373","author":"Bergstrom","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J. Bone Min. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: Current status","volume":"12","author":"Roelofs","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4161\/sgtp.2.3.16453","article-title":"The regulation of osteoclast function and bone resorption by small GTPases","volume":"2","author":"Itzstein","year":"2011","journal-title":"Small GTPases"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI30328","article-title":"Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans","volume":"117","author":"Odgren","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bjp.0706628","article-title":"A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates","volume":"147","author":"Auriola","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.2009.00160.x","article-title":"Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro","volume":"157","author":"Crockett","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bone.2009.08.010","article-title":"The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro","volume":"45","author":"Mitrofan","year":"2009","journal-title":"Bone"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.joms.2020.01.009","article-title":"Medication-Related Osteonecrosis of the Jaw in Patients Taking High-Dose Simvastatin","volume":"78","author":"Giladi","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1080\/10408398.2022.2137724","article-title":"Coenzyme Q10 in aging and disease","volume":"64","author":"Gasmi","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Budzinska, A., and Jarmuszkiewicz, W. (2025). The Cellular and Mitochondrial Consequences of Mevalonate Pathway Inhibition by Nitrogen-Containing Bisphosphonates: A Narrative Review. Pharmaceuticals, 18.","DOI":"10.3390\/ph18071029"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e22778","DOI":"10.1002\/jbt.22778","article-title":"Coenzyme Q10 inhibits RANKL-induced osteoclastogenesis by regulation of mitochondrial apoptosis and oxidative stress in RAW264.7 cells","volume":"35","author":"Zheng","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","article-title":"Skeletal remodeling in health and disease","volume":"13","author":"Zaidi","year":"2007","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","article-title":"Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability","volume":"49","author":"Bellido","year":"2011","journal-title":"Bone"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.oraloncology.2010.12.003","article-title":"Geranylgeraniol\u2014A new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw","volume":"47","author":"Ziebart","year":"2011","journal-title":"Oral Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"770899","DOI":"10.3389\/fcell.2021.770899","article-title":"Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jobcr.2024.01.014","article-title":"Geranylgeraniol (GGOH), incorporated into a bone cement pellet promotes osteoclast function and healing in a model of medication-related osteonecrosis of the jaw","volume":"14","author":"Feldman","year":"2024","journal-title":"J. Oral Biol. Craniofac Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Jung, J., Park, J.S., Chun, J., Al-Nawas, B., Ziebart, T., and Kwon, Y.D. (2023). Geranylgeraniol Application in Human Osteoblasts and Osteoclasts for Reversal of the Effect of Bisphosphonates. Life, 13.","DOI":"10.3390\/life13061353"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2023.06.022","article-title":"Menaquinone-4 prevents medication-related osteonecrosis of the jaw through the SIRT1 signaling-mediated inhibition of cellular metabolic stresses-induced osteoblast apoptosis","volume":"206","author":"Cui","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e70114","DOI":"10.1111\/cpr.70114","article-title":"Soluble Sema4D From \u03b3\u03b4 T Cells Exerts Osteoblast Inhibition via Plexin-B\/mTOR Signalling Contributing to Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaws","volume":"59","author":"Ou","year":"2026","journal-title":"Cell Prolif."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000528376","article-title":"Semaphorin 4D Promotes Osteoclast Formation but Inhibits Osteoblast Formation: Implication in Bisphosphonate-Related Osteonecrosis of the Jaw","volume":"108","author":"Liu","year":"2023","journal-title":"Pharmacology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2016.10.012","article-title":"Possible pathogenic engagement of soluble Semaphorin 4D produced by \u03b3\u03b4T cells in medication-related osteonecrosis of the jaw (MRONJ)","volume":"480","author":"Movila","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_41","first-page":"2071","article-title":"V\u03b39V\u03b42 T cells inhibit immature dendritic cell transdifferentiation into osteoclasts through downregulation of RANK, c Fos and ATP6V0D2","volume":"42","author":"Zhu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bonr.2015.10.004","article-title":"Activation status of \u03b3\u03b4 T cells dictates their effect on osteoclast generation and bone resorption","volume":"3","author":"Phalke","year":"2015","journal-title":"Bone Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cei.12165","article-title":"Activated \u03b3\u03b4 T cells inhibit osteoclast differentiation and resorptive activity in vitro","volume":"174","author":"Pappalardo","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/cas.16401","article-title":"Elotuzumab-mediated ADCC with Th1-like V\u03b39V\u03b42 T cells to disrupt myeloma-osteoclast interaction","volume":"116","author":"Inoue","year":"2025","journal-title":"Cancer Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.2174\/138161210793563545","article-title":"Nitrogen-containing bisphosphonates and cancer immunotherapy","volume":"16","author":"Massaia","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.4049\/jimmunol.1002697","article-title":"Indirect stimulation of human V\u03b32V\u03b42 T cells through alterations in isoprenoid metabolism","volume":"187","author":"Wang","year":"2011","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00018-013-1495-x","article-title":"Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood \u03b3\u03b4 T cells","volume":"71","author":"Kalyan","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jbmr.1769","article-title":"Can peripheral blood \u03b3\u03b4 T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapy","volume":"28","author":"Kalyan","year":"2013","journal-title":"J. Bone Min. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/imm.13931","article-title":"Human \u03b3\u03b4 T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition","volume":"175","author":"Suen","year":"2025","journal-title":"Immunology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","article-title":"A validated regulatory network for Th17 cell specification","volume":"151","author":"Ciofani","year":"2012","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.immuni.2008.03.001","article-title":"Th17 cell differentiation: The long and winding road","volume":"28","author":"McGeachy","year":"2008","journal-title":"Immunity"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","article-title":"Regulatory T Cell Development","volume":"38","author":"Savage","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: Mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/intimm\/dxaf032","article-title":"Cellular metabolism in Th9, Th17, and Treg cell differentiation","volume":"37","author":"Kanno","year":"2025","journal-title":"Int. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Hu, Y., Zhao, Q., Dai, H., Wu, Y., Tang, X., Zhang, N., Jiang, H., Rui, H., and Liu, B. (2025). Metabolic reprogramming as a therapeutic target for modulating the Th17\/Treg balance in autoimmune diseases: A comprehensive review. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1687755"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/ar2502","article-title":"Immune regulation of bone loss by Th17 cells","volume":"10","author":"Adamopoulos","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcdb.2021.05.014","article-title":"Interaction between bone and immune cells: Implications for postmenopausal osteoporosis","volume":"123","author":"Fischer","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_60","first-page":"866","article-title":"Dynamic visualization of RANKL and Th17-mediated osteoclast function","volume":"123","author":"Kikuta","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.23138","article-title":"Treg cells suppress osteoclast formation: A new link between the immune system and bone","volume":"56","author":"Zaiss","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Fischer, L., Herkner, C., Kitte, R., Dohnke, S., Riewaldt, J., Kretschmer, K., and Garbe, A.I. (2019). Foxp3+ Regulatory T Cells in Bone and Hematopoietic Homeostasis. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00578"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s12015-025-11015-2","article-title":"Bone Marrow Mesenchymal Stromal Cell Osteogenesis is driven by Paracrine signals from Regulatory T Cell","volume":"22","author":"Baysal","year":"2026","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jbmr.37","article-title":"Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice","volume":"25","author":"Kikuiri","year":"2010","journal-title":"J. Bone Min. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1089\/scd.2012.0615","article-title":"Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in Swine","volume":"22","author":"Li","year":"2013","journal-title":"Stem Cells Dev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.oooo.2024.08.013","article-title":"Digoxin attenuates bisphosphonate related osteonecrosis of the jaws by ROR\u03b3t-dependent Th17 response in male rats","volume":"138","author":"Lemos","year":"2024","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: Nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Hickman, E., Smyth, T., Cobos-Uribe, C., Immormino, R., Rebuli, M.E., Moran, T., Alexis, N.E., and Jaspers, I. (2023). Expanded characterization of in vitro polarized M0, M1, and M2 human monocyte-derived macrophages: Bioenergetic and secreted mediator profiles. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0279037"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1165\/rcmb.2015-0012OC","article-title":"Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages","volume":"53","author":"Tarique","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/JLB.1MA0121-001R","article-title":"Macrophage M1\/M2 polarization dynamically adapts to changes in microenvironment and modulates alveolar bone remodeling after dental implantation","volume":"110","author":"Liang","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.2147\/JIR.S484529","article-title":"Inhibition of EGFR Pathway Suppresses M1 Macrophage Polarization and Osteoclastogenesis, Mitigating Titanium Particle-Induced Bone Resorption","volume":"17","author":"Jia","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"16137","DOI":"10.1038\/s41598-025-99772-5","article-title":"The alterations of molecular repertoire of the RANKL-induced osteoclastogenesis in the M1 macrophage-derived inflammatory milieu","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"105509","DOI":"10.1016\/j.jdent.2024.105509","article-title":"Tideglusib enhances ALP activity and upregulates RANKL expression in Osteoblast-macrophage Co-cultures within a 3D collagen scaffold","volume":"153","author":"Toledano","year":"2025","journal-title":"J. Dent."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/odi.13167","article-title":"M1 macrophages regulate TLR4\/AP1 via paracrine to promote alveolar bone destruction in periodontitis","volume":"25","author":"Zhu","year":"2019","journal-title":"Oral Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"112441","DOI":"10.1016\/j.mce.2024.112441","article-title":"Liraglutide promotes osteogenic differentiation of mesenchymal stem cells by inhibiting M1 macrophage polarization and CXCL9 release in vitro","volume":"597","author":"He","year":"2025","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz, J., Akhavan, N.S., Mullins, A.P., and Arjmandi, B.H. (2020). Macrophage Polarization and Osteoporosis: A Review. Nutrients, 12.","DOI":"10.3390\/nu12102999"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41413-024-00361-5","article-title":"Periostin+ myeloid cells improved long bone regeneration in a mechanosensitive manner","volume":"12","author":"Wang","year":"2024","journal-title":"Bone Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"680328","DOI":"10.3389\/fendo.2021.680328","article-title":"Exosomes Derived From M2 Macrophages Facilitate Osteogenesis and Reduce Adipogenesis of BMSCs","volume":"12","author":"Li","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"102645","DOI":"10.1016\/j.tice.2024.102645","article-title":"Exosomes secreted from M2-polarized macrophages inhibit osteoclast differentiation via CYLD","volume":"93","author":"Guo","year":"2025","journal-title":"Tissue Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e72430","DOI":"10.7554\/eLife.72430","article-title":"Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophages","volume":"10","author":"Munoz","year":"2021","journal-title":"eLife"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/odi.12908","article-title":"Alteration of macrophage viability, differentiation, and function by bisphosphonates","volume":"24","author":"Patntirapong","year":"2018","journal-title":"Oral Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00784-014-1358-3","article-title":"Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"19","author":"Hoefert","year":"2015","journal-title":"Clin. Oral Investig."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00784-015-1584-3","article-title":"Altered macrophagic THP-1 cell phagocytosis and migration in bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"20","author":"Hoefert","year":"2016","journal-title":"Clin. Oral Investig."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41232-018-0074-9","article-title":"Zoledronic acid exacerbates inflammation through M1 macrophage polarization","volume":"38","author":"Kaneko","year":"2018","journal-title":"Inflamm. Regen."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Weber, M., Homm, A., M\u00fcller, S., Frey, S., Amann, K., Ries, J., Geppert, C., Preidl, R., M\u00f6st, T., and K\u00e4mmerer, P.W. (2021). Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031323"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1096\/fj.201801791RR","article-title":"Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw","volume":"33","author":"Zhu","year":"2019","journal-title":"FASEB J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/00220345241258990","article-title":"Macrophage Polarization during MRONJ Development in Mice","volume":"103","author":"Soundia","year":"2024","journal-title":"J. Dent. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"144342","DOI":"10.1016\/j.ijbiomac.2025.144342","article-title":"Protein O-GlcNAcylation reprograms macrophage-mediated bone remodeling in medication-related osteonecrosis of the jaw","volume":"313","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12964-024-01659-x","article-title":"O-GlcNAcylation: Roles and potential therapeutic target for bone pathophysiology","volume":"22","author":"Yan","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2025.10.001","article-title":"Reprogramming natural killer cells in the tumor microenvironment: Challenges and therapeuticopportunities","volume":"86","author":"Ma","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1182\/blood-2011-01-328526","article-title":"DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by \u03b3\u03b4 T lymphocytes","volume":"118","author":"Nussbaumer","year":"2011","journal-title":"Blood"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"20002","DOI":"10.18632\/oncotarget.4755","article-title":"Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclast-mediated NK cell activation","volume":"6","author":"Tseng","year":"2015","journal-title":"Oncotarget"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.3892\/or.2013.2350","article-title":"Zoledronic acid negatively affects the expansion of in vitro activated human NK cells and their cytolytic interactions with Ewing sarcoma cells","volume":"29","author":"Mueller","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_99","first-page":"41","article-title":"The content of nk cells and their subtypes in the case of drug-induced jaw osteonecrosis","volume":"306","author":"Ivanyushko","year":"2020","journal-title":"Georgian Med. News"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41423-025-01380-w","article-title":"Neutrophils as critical orchestrators of chronic inflammation","volume":"23","author":"Torfs","year":"2026","journal-title":"Cell Mol. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1016\/j.cell.2025.11.001","article-title":"The neutrophil collective","volume":"188","author":"Ballesteros","year":"2025","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Gierlikowska, B., Stachura, A., Gierlikowski, W., and Demkow, U. (2021). Phagocytosis, Degranulation and Extracellular Traps Release by Neutrophils-The Current Knowledge, Pharmacological Modulation and Future Prospects. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.666732"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1074\/jbc.M408820200","article-title":"Rac GTPase isoform-specific regulation of NADPH oxidase and chemotaxis in murine neutrophils in vivo. Role of the C-terminal polybasic domain","volume":"280","author":"Yamauchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Tackenberg, H., M\u00f6ller, S., Filippi, M.D., and Laskay, T. (2020). The Small GTPase Cdc42 Is a Major Regulator of Neutrophil Effector Functions. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01197"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1476-5381.2011.01592.x","article-title":"Zoledronate and pamidronate depress neutrophil functions and survival in mice","volume":"165","author":"Kuiper","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/jbmr.4384","article-title":"Nitrogen-containing bisphosphonates and lipopolysaccharide mutually augment inflammation via adenosine triphosphate (ATP)-mediated and interleukin 1\u03b2 IL-1\u03b2-mediated production of neutrophil extracellular traps (NETs)","volume":"36","author":"Bando","year":"2021","journal-title":"J. Bone Min. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"18309","DOI":"10.1038\/s41598-020-75272-6","article-title":"The effect of pamidronate delivery in bisphosphonate-na\u00efve patients on neutrophil chemotaxis and oxidative burst","volume":"10","author":"Chadwick","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e70073","DOI":"10.1111\/imr.70073","article-title":"Dendritic Cells: Orchestrators of Immune Responsiveness and Tolerance","volume":"336","author":"Polonio","year":"2025","journal-title":"Immunol. Rev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Wculek","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s43556-025-00300-8","article-title":"Dendritic cells: Understanding ontogeny, subsets, functions, and their clinical applications","volume":"6","author":"Li","year":"2025","journal-title":"Mol. Biomed."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-020-02433-6","article-title":"Boning up: Amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection","volume":"18","author":"Brufsky","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.leu.2404556","article-title":"Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells","volume":"21","author":"Bringmann","year":"2007","journal-title":"Leukemia"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1096\/fj.201901819RR","article-title":"Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw","volume":"34","author":"Elsayed","year":"2020","journal-title":"FASEB J."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41577-024-01062-0","article-title":"Defining myeloid-derived suppressor cells","volume":"24","author":"Akkari","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12967-025-06214-x","article-title":"Monocytic myeloid-derived suppressor cells contribute to the exacerbation of bone destruction in periodontitis","volume":"23","author":"Zhou","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e14298","DOI":"10.1111\/acel.14298","article-title":"Age-related increase of CD38 directs osteoclastogenic potential of monocytic myeloid-derived suppressor cells through mitochondrial dysfunction in male mice","volume":"23","author":"Thiyagarajan","year":"2024","journal-title":"Aging Cell"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e76207","DOI":"10.7554\/eLife.76207","article-title":"Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene diphosphonate","volume":"11","author":"Okawa","year":"2022","journal-title":"eLife"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/jdv.19935","article-title":"The role of interleukin-36 in health and disease states","volume":"38","author":"Sugiura","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41388-025-03293-4","article-title":"The complex roles of IL-36 and IL-38 in cancer: Friends or foes?","volume":"44","author":"Finucane","year":"2025","journal-title":"Oncogene"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jbmr.2985","article-title":"IL-36 Induces Bisphosphonate-Related Osteonecrosis of the Jaw-Like Lesions in Mice by Inhibiting TGF-\u03b2-Mediated Collagen Expression","volume":"32","author":"Kim","year":"2017","journal-title":"J. Bone Min. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12967-025-06122-0","article-title":"Exploring TNFR1: From discovery to targeted therapy development","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.4110\/in.2024.24.e4","article-title":"TNF in Human Tuberculosis: A Double-Edged Sword","volume":"24","author":"Yuk","year":"2024","journal-title":"Immune Netw."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/ijmm.2022.5098","article-title":"Tumor necrosis factor \u03b1 in systemic lupus erythematosus: Structure, function and therapeutic implications (Review)","volume":"49","author":"Ghorbaninezhad","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"116168","DOI":"10.1016\/j.bone.2021.116168","article-title":"Biologic and pathologic aspects of osteocytes in the setting of medication-related osteonecrosis of the jaw (MRONJ)","volume":"153","author":"Aguirre","year":"2021","journal-title":"Bone"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"46322","DOI":"10.1038\/srep46322","article-title":"Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis","volume":"7","author":"Morita","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00774-020-01174-2","article-title":"Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw","volume":"39","author":"Soma","year":"2021","journal-title":"J. Bone Min. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Pabst, A.M., Kr\u00fcger, M., Blatt, S., Ziebart, T., Rahimi-Nedjat, R., Goetze, E., and Walter, C. (2016). Angiogenesis in the Development of Medication-Related Osteonecrosis of the Jaws: An Overview. Dent. J., 5.","DOI":"10.3390\/dj5010002"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00784-009-0365-2","article-title":"Bisphosphonates: Restrictions for vasculogenesis and angiogenesis: Inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro","volume":"15","author":"Ziebart","year":"2011","journal-title":"Clin. Oral Investig."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"20580","DOI":"10.1038\/srep20580","article-title":"The effect of bisphosphonates on the endothelial differentiation of mesenchymal stem cells","volume":"6","author":"Sharma","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"101812","DOI":"10.1016\/j.bonr.2024.101812","article-title":"Zoledronate interrupts pre-osteoclast-induced angiogenesis via SDF-1\/CXCR4 pathway","volume":"23","author":"Awad","year":"2024","journal-title":"Bone Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood-2009-08-237628","article-title":"Osteoclasts are important for bone angiogenesis","volume":"115","author":"Cackowski","year":"2010","journal-title":"Blood"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cyto.2014.10.025","article-title":"The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells","volume":"71","author":"Ishtiaq","year":"2015","journal-title":"Cytokine"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e159865","DOI":"10.1172\/jci.insight.159865","article-title":"Macrophage miR-149-5p induction is a key driver and therapeutic target for BRONJ","volume":"7","author":"Shen","year":"2022","journal-title":"JCI Insight"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e70082","DOI":"10.1002\/ctm2.70082","article-title":"Targeting endoplasmic reticulum stress-induced lymphatic dysfunction for mitigating bisphosphonate-related osteonecrosis","volume":"14","author":"Qin","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"115117","DOI":"10.1016\/j.bone.2019.115117","article-title":"PDGF-BB exhibited therapeutic effects on rat model of bisphosphonate-related osteonecrosis of the jaw by enhancing angiogenesis and osteogenesis","volume":"144","author":"Gao","year":"2021","journal-title":"Bone"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"700","DOI":"10.12659\/MSM.911579","article-title":"Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)\/Akt\/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway","volume":"25","author":"Wang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Ziebart, T., Halling, F., Heymann, P., Neff, A., Blatt, S., Jung, J., Pabst, A., Righesso, L., and Walter, C. (2016). Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ). Dent. J., 4.","DOI":"10.20944\/preprints201610.0060.v1"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0022034511402995","article-title":"Bisphosphonates induce senescence in normal human oral keratinocytes","volume":"90","author":"Kim","year":"2011","journal-title":"J. Dent. Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00784-010-0507-6","article-title":"The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes\u2014In vitro study","volume":"16","author":"Pabst","year":"2012","journal-title":"Clin. Oral Investig."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Bullock, G., Miller, C., McKechnie, A., and Hearnden, V. (2020). Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro. Materials, 13.","DOI":"10.3390\/ma13092086"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2340\/aos.v85.45585","article-title":"Bisphosphonate and statin: Adverse effects of co-medication on wound healing in in vitro models of periodontal tissues","volume":"85","author":"Agger","year":"2026","journal-title":"Acta Odontol. Scand."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/odi.13412","article-title":"Endothelial progenitors increase vascularization and improve fibroblasts function that prevent medication-related osteonecrosis of the jaw","volume":"26","author":"Doppelt","year":"2020","journal-title":"Oral Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ijos.2014.46","article-title":"Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw","volume":"6","author":"Pushalkar","year":"2014","journal-title":"Int. J. Oral Sci."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Jelin-Uhlig, S., Weigel, M., Ott, B., Imirzalioglu, C., Howaldt, H.P., B\u00f6ttger, S., and Hain, T. (2024). Bisphosphonate-Related Osteonecrosis of the Jaw and Oral Microbiome: Clinical Risk Factors, Pathophysiology and Treatment Options. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158053"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Yahara, H., Hiraki, A., Maruoka, Y., Hirabayashi, A., Suzuki, M., and Yahara, K. (2020). Shotgun metagenome sequencing identification of a set of genes encoded by Actinomyces associated with medication-related osteonecrosis of the jaw. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241676"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"106180","DOI":"10.1016\/j.archoralbio.2025.106180","article-title":"Next-generation sequencing analysis of bacterial species present in the sequestrum of medication-related osteonecrosis of the jaw patients","volume":"172","author":"Choi","year":"2025","journal-title":"Arch. Oral Biol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1851112","DOI":"10.1080\/20002297.2020.1851112","article-title":"Porphyromonas, Treponema, and Mogibacterium promote IL8\/IFN\u03b3\/TNF\u03b1-based pro-inflammation in patients with medication-related osteonecrosis of the jaw","volume":"13","author":"Li","year":"2020","journal-title":"J. Oral Microbiol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Badros, A.Z., Meddeb, M., Weikel, D., Philip, S., Milliron, T., Lapidus, R., Hester, L., Goloubeva, O., Meiller, T.F., and Mongodin, E.F. (2021). Prospective Observational Study of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma: Microbiota Profiling and Cytokine Expression. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.704722"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1177\/0022034511420430","article-title":"A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw","volume":"90","author":"Mawardi","year":"2011","journal-title":"J. Dent. Res."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Wu, S., Li, F., Tan, J., Ye, X., Le, Y., Liu, N., Everts, V., and Wan, Q. (2022). Porphyromonas gingivalis Induces Bisphosphonate-Related Osteonecrosis of the Femur in Mice. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.886411"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1248\/yakushi.19-00125","article-title":"Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates","volume":"140","author":"Endo","year":"2020","journal-title":"Yakugaku Zasshi"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12967-015-0568-z","article-title":"Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw","volume":"13","author":"Kalyan","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41368-022-00166-4","article-title":"Indigenous microbiota protects development of medication-related osteonecrosis induced by periapical disease in mice","volume":"14","author":"Du","year":"2022","journal-title":"Int. J. Oral Sci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cre2.698","article-title":"Incidence and risk factors for medication-related osteonecrosis after tooth extraction in cancer patients-A systematic review","volume":"9","author":"Schwech","year":"2023","journal-title":"Clin. Exp. Dent. Res."},{"key":"ref_159","first-page":"2509","article-title":"Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)","volume":"29","author":"Kizub","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"105051","DOI":"10.1016\/j.jdent.2024.105051","article-title":"Influence of the use of bisphosphonates on the development of postextraction sequelae: Scoping review with mapping evidence of in vivo studies","volume":"148","author":"Dias","year":"2024","journal-title":"J. Dent."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/clr.12502","article-title":"Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats","volume":"27","author":"Li","year":"2016","journal-title":"Clin. Oral Implant. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J. Bone Min. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/jbmr.4614","article-title":"Long-Term Ligature-Induced Periodontitis Exacerbates Development of Bisphosphonate-Related Osteonecrosis of the Jaw in Mice","volume":"37","author":"Williams","year":"2022","journal-title":"J. Bone Min. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.joen.2016.07.020","article-title":"Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice","volume":"42","author":"Song","year":"2016","journal-title":"J. Endod."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jbmr.1894","article-title":"Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice","volume":"28","author":"Kang","year":"2013","journal-title":"J. Bone Min. Res."},{"key":"ref_166","first-page":"1053","article-title":"Analysis of potential risk factors for the development of medication-related osteonecrosis of the jaw","volume":"62","author":"Szuta","year":"2025","journal-title":"Dent. Med. Probl."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Stelea, C.G., Bologa, E., Boi\u0219teanu, O., Platon, A.L., Stelea, \u0218.O., Gele\u021bu, G.L., Onic\u0103, C.A., \u0218ulea, D., Ciofu, M.L., and Costan, V.V. (2025). Bisphosphonate-Related Osteonecrosis of the Jaw: A 10-Year Analysis of Risk Factors and Clinical Outcomes. J. Clin. Med., 14.","DOI":"10.20944\/preprints202505.1868.v1"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1210\/jc.2013-2434","article-title":"Diabetes microvascular disease and the risk for bisphosphonate-related osteonecrosis of the jaw: A single center study","volume":"98","author":"Molcho","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_170","first-page":"e390","article-title":"Occurrence of bisphosphonate-associated osteonecrosis of the jaws in individuals with rheumatoid arthritis\u2014A systematic review","volume":"29","author":"Estanho","year":"2024","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"117623","DOI":"10.1016\/j.bone.2025.117623","article-title":"Understanding the genetic basis of medication-related osteonecrosis of the jaw: A systematic review","volume":"201","author":"Radi","year":"2025","journal-title":"Bone"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Bojtor, B., Balla, B., Vaszilko, M., Szentpeteri, S., Putz, Z., Kosa, J.P., and Lakatos, P. (2024). Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910488"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"eaav9166","DOI":"10.1126\/scitranslmed.aav9166","article-title":"ATRAID regulates the action of nitrogen-containing bisphosphonates on bone","volume":"12","author":"Surface","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Kim, S., Mun, S., Shin, W., Han, K., and Kim, M.Y. (2022). Identification of Potentially Pathogenic Variants Associated with Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ) Patients Using Whole-Exome Sequencing. J. Clin. Med., 11.","DOI":"10.3390\/jcm11082145"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: A genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3324\/haematol.2011.042572","article-title":"CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma","volume":"96","author":"Such","year":"2011","journal-title":"Haematologica"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jbmr.4185","article-title":"SIRT1 Gene SNP rs932658 Is Associated With Medication-Related Osteonecrosis of the Jaw","volume":"36","author":"Yang","year":"2021","journal-title":"J. Bone Min. Res."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Bojtor, B., Vaszilko, M., Armos, R., Tobias, B., Podani, J., Szentpeteri, S., Balla, B., Lengyel, B., Piko, H., and Illes, A. (2024). Analysis of SIRT1 Gene SNPs and Clinical Characteristics in Medication-Related Osteonecrosis of the Jaw. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073646"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Choi, S.Y., Kim, J.W., Oh, S.H., Cheon, S., Yee, J., Kim, S.J., Gwak, H.S., and Chung, J.E. (2023). Prediction of medication-related osteonecrosis of the jaws using machine learning methods from estrogen receptor 1 polymorphisms and clinical information. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1140620"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2011-0202","article-title":"Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: The role of RBMS3","volume":"17","author":"Nicoletti","year":"2012","journal-title":"Oncologist"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Kim, J.S., Kim, J.W., Yee, J., Kim, S.J., Chung, J.E., and Gwak, H.S. (2023). Interactive Associations between PPAR\u03b3 and PPARGC1A and Bisphosphonate-Related Osteonecrosis of the Jaw in Patients with Osteoporosis. Pharmaceuticals, 16.","DOI":"10.3390\/ph16071035"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/cpt.2397","article-title":"Genome-wide Association Study Identified Chromosome 8 Locus Associated with Medication-Related Osteonecrosis of the Jaw","volume":"110","author":"Yang","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-0714.2010.01004.x","article-title":"Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws","volume":"40","author":"Arduino","year":"2011","journal-title":"J. Oral Pathol. Med."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/8\/835\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:14:36Z","timestamp":1787112876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/8\/835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":183,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cimb48080835"],"URL":"https:\/\/doi.org\/10.3390\/cimb48080835","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}